REAL WORLD EVALUATION OF MAJOR BLEEDING RISK AND COSTS FOR ALL CAUSES AND BLEEDING-RELATED HEALTH SERVICES AMONG ELDERLY PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION TREATED WITH APIXABAN OR WARFARIN
Conclusions: In the real-world setting after balancing patient characteristics, apixaban treatment is associated with significantly lower risk of major bleeding as well as significantly lower costs for all causes and bleeding-related health services among elderly NVAF patients in the US.
Gespeichert in:
Veröffentlicht in: | Journal of the American College of Cardiology 2017-03, Vol.69 (11), p.312-312 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Conclusions: In the real-world setting after balancing patient characteristics, apixaban treatment is associated with significantly lower risk of major bleeding as well as significantly lower costs for all causes and bleeding-related health services among elderly NVAF patients in the US. |
---|---|
ISSN: | 0735-1097 1558-3597 |
DOI: | 10.1016/S0735-1097(17)33701-4 |